01-06-2020 | Melanoma | Case report
Disulfiram/interferon-α-2b/ pembrolizumab
Posterior reversible encephalopathy syndrome, reversible hypertension and fatigue: case report
Published in: Reactions Weekly | Issue 1/2020
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event